Trials / Sponsors / Novita Pharmaceuticals, Inc.
Novita Pharmaceuticals, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1) Platinum-resistant Ovarian Cancer | Phase 2 / Phase 3 | 2025-12-29 |
| Active Not Recruiting | NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignanc Advanced or Metastatic Solid Tumor Malignancies | Phase 1 / Phase 2 | 2021-12-07 |
| Completed | Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Breast Cancer, Pancreas Cancer, Prostate Cancer | Phase 1 | 2017-12-21 |